Facilitated By

San Antonio Medical Foundation

Evaluate the immunogenicity and protective efficacy of pGX9501 (INO-4800) in the Rhesus macaque model of SARS-CoV-2 challenge

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Carrion, Ricardo
Research Start Date
Status
Active

The purpose of this study will be to evaluate the immunogenicity and protective efficacy of pGX9501 (INO-4800) at a 0.5mg and 1 mg dose in the Rhesus macaque model of SARS-CoV-2 challenge.						

Collaborative Project
Drug Discovery
Infectious Disease